- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03977246
Effect of Open-placebo Intervention on Cycling Performance
June 5, 2019 updated by: Bruno Gualano, University of Sao Paulo
The Effect of an Open-placebo Intervention on Cycling Time-trial Performance
This study evaluates the effect of an open-label placebo intervention on cycling time-trial performance.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study investigated the effect of open-placebo on cycling time-trial (TT) performance.
Twenty-eight trained female cyclists completed a 1-km cycling TT following a control session or an open-placebo intervention.
The intervention consisted of an individual presentation, provided by a medic, in which the concept of open-placebo was explained to the participant, before she ingested two red and white capsules containing flour; 15 min later, they performed the TT.
In the control session, the participant sat quietly for 20 min.
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sao Paulo, Brazil, 05508-30
- University of Sao Paulo
-
Sao Paulo, Brazil, 05508030
- School of Physical Education and Sport - USP
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Females aged between 18 and 45 years old;
- A minimum of one-year training experience in cycling.
Exclusion Criteria:
- Smokers
- Chronic disease
- Prior or current use of steroids
- Use of creatine in the last 6 months
- Use of beta-alanine in the last 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Open-placebo
The open-placebo intervention session
|
Application of the open-placebo intervention
|
|
Placebo Comparator: Control
The control session
|
Application of the control session
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exercise performance
Time Frame: 20-min following open-placebo intervention
|
Change in 1 km cycling time-trial performance
|
20-min following open-placebo intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood lactate
Time Frame: Immediately post-exercise
|
Change in blood lactate concentration
|
Immediately post-exercise
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bruno Gualano, PhD, University of Sao Paulo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2018
Primary Completion (Actual)
August 30, 2018
Study Completion (Actual)
September 30, 2018
Study Registration Dates
First Submitted
June 4, 2019
First Submitted That Met QC Criteria
June 4, 2019
First Posted (Actual)
June 6, 2019
Study Record Updates
Last Update Posted (Actual)
June 7, 2019
Last Update Submitted That Met QC Criteria
June 5, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- OpenPlaceboCycling
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise Performance
-
Lindenwood UniversityCompletedExercise Performance | Exercise Performance of Fit Athletes | Cycling PerformanceUnited States
-
University of GaziantepCompletedExercise Performance | Physical PerformanceTurkey (Türkiye)
-
Applied Science & Performance InstituteCompletedMood | Endurance Exercise | Exercise Performance | Energy | Physical Performance | Perceived ExertionUnited States
-
California Polytechnic State University-San Luis...Recruiting
-
Chih-Hui ChiuNational Science and Technology Council, TaiwanCompleted
-
Nanyang Technological UniversityCompleted
-
Glac Biotech Co., LtdCompletedExercise PerformanceTaiwan
-
Northumbria UniversityMibelle Group Biochemistry; Haskapa LtdCompleted
-
California Polytechnic State University-San Luis...Completed
-
PepsiCo Global R&DCompletedExercise PerformanceUnited Kingdom
Clinical Trials on Open-placebo
-
University of Auckland, New ZealandNot yet recruiting
-
Massachusetts General HospitalNational Center for Complementary and Integrative Health (NCCIH); Harvard UniversityCompletedMajor Depressive DisorderUnited States
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruiting
-
Alector Inc.GlaxoSmithKlineTerminatedFrontotemporal DementiaSpain, United States, United Kingdom, France, Netherlands, Belgium, Germany, Italy, Australia, Portugal, Switzerland, Argentina, Canada, Greece, Sweden, Turkey (Türkiye)
-
M.D. Anderson Cancer CenterRecruitingFatigue | Metastatic CancersUnited States
-
Dogwood Therapeutics Inc.RecruitingChemotherapy Induced Neuropathic Pain | Chemotherapy Induced Pain Neuropathy | Chemotherapy Induced PainUnited States
-
University of Maryland, BaltimoreRecruiting
-
Spaulding Rehabilitation HospitalRecruiting
-
Studio Osteopatico Busto ArsizioCompleted